UCLH Brain Tumour Service awarded ‘Tessa Jowell Centre of Excellence Status’

The Brain Tumour Unit at the National Hospital for Neurology and Neurosurgery (NHNN) at UCLH has become a ‘Tessa Jowell Centre of Excellence’ in recognition of its world class brain tumour service and research activity.

The award, announced on 2 March 2021, recognises the delivery of outstanding care and treatment by NHS staff and delivery of clinical trials. The award is part of a national strategy to improve care for people with brain tumours by the Tessa Jowell Brain Cancer Mission.

The Centre of Excellence status, based on a range of criteria, includes excellent clinical practice and training opportunities; emphasis on patient quality of life; providing clinical trials and offering a high standard of research opportunities.

The status is a reflection of the Unit’s clinical strengths through the integration of research and education and leadership, across our community of scientists, clinicians and clinical scientists across UCLH & UCL.

This is part of a wider BRC Neuro-Oncology initiative to drive forward research for brain cancers alongside patient advocacy.

To find out more about our vision for brain cancer research, contact morium.ali -at- ucl.ac.uk.

Image: Dr Naomi Fersht, consultant clinical oncologist at UCLH and the NHNN, who led the application.